FT商学院

Drugmaker Eisai secures ESG money by linking investments to value
制药商卫材是如何通过将投资与价值挂钩来获得ESG资金的?

‘Hard numbers’ model designed by ex-head of finance is winning followers among leading investors and corporate Japan
由前财务主管设计的“硬数据”模型正在日本的主要投资者和企业中赢得追捧。

You could be forgiven for expecting a former chief financial officer at Eisai, a conservative, family-run Japanese pharmaceutical company, to be a buttoned-up number-cruncher. You might imagine someone focused solely on obscure financial metrics, earnings reports, and margin calculations.

卫材(Eisai)是一家保守的、家族式经营的日本制药公司,你可以理解为卫材的前首席财务官是一个紧抠的数字计算者。你可能会想象一个只关注晦涩的财务指标、收益报告和利润率计算的人。

您已阅读5%(377字),剩余95%(7118字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×